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hjk776Abstract—Botulinum toxin type A (BoNT-A) injections in the forehead region should only target the frontalis. This
study applied ultrasonography with the aim of providing guidelines for predicting the layered structure and soft-tissue
thickness of the forehead. We performed ultrasound scanning at 7 facial landmarks in 40 Korean adults. Allowing for
the error range, the minimum depth from the skin to exclude the muscle layer was 2.3 mm, and the maximum depth
from the skin to include themuscle layer was 2.8 mm. Of the total 7 points from the skin tomuscle surface, significant dif-
ferences between the males and females were found in 6 points (p< 0.05). Clinicians can use ultrasonography to identify
the structural layers of the scalp. Even if ultrasound-guided injections are not performed, it is possible to target only mus-
cle layers in BoNT-A injections by maintaining a needle depth of around 2.5 mm. (E-mail: hjk776@yuhs.ac) © 2019
The Author(s). Published by Elsevier Inc. on behalf of World Federation for Ultrasound in Medicine & Biology. This is
an open access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Wrinkles on the forehead contribute to the aesthetic func-
tion of the face. These wrinkles are caused by the contrac-
tion and relaxation of facial expression muscles, and they
are concentrated in areas related to emotional expressions
such as the forehead, eyes, nose and mouth. These wrinkles
are not clearly evident on an expressionless face, and can
be used to create an exaggerated appearance in emotional
expressions (Arnaoutakis et al. 2018; Wieder et al. 1998).
The forehead is a cosmetically important area, but it
is also the region where headaches occur internally.
Headaches are pains that anyone can experience in
everyday life. Among them, the tension-type headache,
which occurs in the forehead, causes a dull, non-pulsatile
pain similar to wearing a tight headband on both sides of
the forehead and temporal region (Amirlak et al. 2018;
Fernandez-de-Las-Pe~nas et al. 2006).
Botulinum toxin type A (BoNT-A) injections are
widely used to treat both facial wrinkles and tension-typeddress correspondence to: Hee-Jin Kim, Department of Oral
y, Yonsei University College of Dentistry, Room 601, 50-1
-ro, Seodaemun-gu, Seoul 03722, Republic of Korea. E-mail:
@yuhs.ac
2641headaches (Blumenfeld et al. 2010; Carruthers et al. 2003,
2008). The most important point in BoNT-A injectable pro-
cedure is to identify the target layer. Injections in the fore-
head region should target only the frontalis (Ascher et al.
2010; Choi et al. 2016). Making injections more accurate
and effective requires a sound knowledge of the anatomic
structures of the forehead. This study therefore applied
ultrasonography with the aim of providing guidelines for
predicting the layered structure and soft tissue thickness of
the forehead.METHODS
Patients
From June to August 2017, 40 Korean adults partic-
ipated in this study (23 males and 17 female, mean age:
24.3 y). Because the consumers in the aesthetics market
are predominantly young, patients in their twenties were
preferentially recruited for this study. The volunteers
were allowed to participate in the study once only, and
their participation took about 2 h. Each volunteer was
placed in a semisupine position, and landmarks were
marked on the face. The examiner sat adjacent to the vol-
unteer’s head to record ultrasound images. A real-time
2642 Ultrasound in Medicine & Biology Volume 45, Number 10, 2019ultrasound scanner (E-CUBE 15 EX, ALPINION, Seoul,
Korea) with a 30-mm-wide linear-array transducer
(8.017.0 MHz; IO8-17 High-Frequency Hockey Stick,
Seoul, Korea) was used in this study. The ultrasound
gel (SONO JELLY, MEDITOP Corporation, Youngin,
Korea) used for this study caused no irritation to the skin
because its components are harmless to the human body,
and facial cleansers and moisturizers were prepared for
the convenience of the volunteers.
All of the study procedures were approved by the
institutional review board of the Yonsei University Col-
lege of Dentistry (IRB No. 2-2017-0023), and they were
fully explained to the volunteers, who then provided
written consent forms.
Measurement protocol
We performed ultrasound scanning at seven facial
landmarks (only on the left side, including the midline).
We first defined the midsagittal line as VL1. On this
line, the point meeting the hair line was defined as point
1, the midpoint between the two frontal eminences (point
4) as point 2 and the midpoint between point 2 and the
glabella as point 3. In addition, the intersection points
between the horizontal line passing through point 3
(HL1) and the vertical lines passing through the medial
canthus (VL2), middle of the pupil (VL3) and lateral
canthus (VL4) were defined as points 5, 6 and 7, respec-
tively (Fig. 1). The soft tissue thickness was measured at
each point using an image analysis program (ImageJ,
National Institutes of Health, Bethesda, MD, USA). The
statistical calculations and analysis were performed
using standard software (SPSS Version 23.0 for Win-
dows, IBM, Armonk, NY, USA). A p value <0.05 was
considered to indicate statistical significance. Differen-
ces in measurement values between males and femalesFig. 1. The seven facial landmarks used in this study: (a) frontal
aspect. (b) oblique aspect. (1) trichion; (2) metopion; (3) halfway
point between point 2 and the glabella; (4) frontal eminence; (5)
meeting point between VL2 and HL1; (6) meeting point between
VL3 and HL1; (7) meeting point between VL4 and HL1.
HL1 = horizontal line passing through point 3; VL1 =midsagittal
line; VL2 = vertical line passing through the medial canthus;
VL3 = vertical line passing through the middle of the pupil;
VL4 = vertical line passing through the lateral canthus.were analyzed using Student’s t test. The soft tissue
thickness was measured using an image analysis pro-
gram (ImageJ) at each point.RESULTS
Anatomy at the seven points
Points 13. Point 1 is the meeting point between
VL1 and the hairline, and so part of the hair can be
observed above the skin in ultrasound images. The fron-
talis is not present in the muscular third layer of the
scalp, and so we considered it to be the galea aponeuro-
tica in ultrasound images (Fig. 2a).
Point 2 is the midpoint between the two frontal emi-
nences. This part is similar to the medial border of the
frontalis that divides into the left and right sides. It is
therefore not possible to clearly identify whether the
third layer in an ultrasound image is the frontalis or the
galea aponeurotica. However, other structures such as
the skin, subcutaneous layer and loose connective tissue
layer could be clearly distinguished (Fig. 2b).
Point 3 is the midpoint between point 2 and the gla-
bella, and only the frontalis exists in this area. We there-
fore observed the frontalis to be thicker than at points 1
and 2 in ultrasound images. There was no significant dif-
ference in the other layers (Fig. 2c).Point 4
Point 4 refers to the left frontal eminence. This is
the area where only the frontalis exists (Fig. 3a). In some
cases (16/40, 40%), a frontal branch of the superficial
temporal artery that travels over the frontalis muscle
may be observed in ultrasound images (Fig. 3b).Points 57
Point 5 is the meeting point between the HL1 and
the VL2, and its layered structure is also clearly distin-
guishable in ultrasound images. Because the muscle
layer appears so thick, in a manner similar to that at point
3, we can consider this point a merging area with the cor-
rugator supercilii muscle. However, this point also
belongs only to the frontalis area (Fig. 4a).
Point 6 is the meeting point between HL1 and VL3.
Compared with point 5, the muscle layer is thinner and
the loose connective tissue layer is thicker. In addition,
the retro-orbicularis oculi fat (ROOF) exists in this
region. ROOF is the one of the types of deep fat of the
face. Fibrous connective tissues pass through facial fat
tissues and play a role in connecting the fat tissue, facial
muscles, dermis and bone. Therefore, we can identify
that the morphology of the loose connective tissue layer
is slightly different from that for points 13 in ultra-
sound images (Fig. 4b).
Fig. 2. Ultrasound transverse views at point 1 (a), point 2 (b) and point 3 (c). The arrows indicate the location of each
point. All images were obtained using a highly linear 15-MHz probe with the maximum depth set to 1.5 cm.
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Fig. 3. Ultrasound transverse view at point 4 (a). The color Doppler imaging mode makes it easy to identify the frontal
branch of the superficial temporal artery (b). The arrow indicates the location of the point. The image was obtained using
a highly linear 15-MHz probe with the maximum depth set to 1.5 cm.
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Fig. 4. Ultrasound transverse views at point 5 (a), point 6 (b) and point 7 (c). The arrows indicate the location of each
point. All images were obtained using a highly linear 15 MHz probe with the maximum depth set to 1.5 cm. An arrow-
head indicates the location of the temporal line. ROOF, retro-orbicularis oculi fat.
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and is observed as a layered structure similar to point 6.
The temporal line can be observed in the lateral part of
point 7, which is the boundary between the forehead and
the temporal fossa (Fig. 4c).Soft tissue thicknesses at the seven points
The soft tissue thicknesses in the various scalp layers
(skin, subcutaneous tissue, muscle and loose connective tis-
sue) are outlined in Table 1. In all cases, the muscle layer
(the third layer of the scalp) is thicker than the other layers,
which makes it easy to identify. In particular, the thickness
exceeded 2 mm at points 3 and 5. The thickness of skin,
subcutaneous tissue and loose connective tissue tended to
differ significantly between males and females, whereas
muscle thickness exhibited no sex-related differences.
The overall soft tissue thickness of the forehead
region ranged from 4.35.3 mm, with an average of 4.7
§ 0.3 mm (mean § standard deviation). The soft tissue
was significantly thicker in males than in females at
every point, except the muscle layer (p < 0.05; Table 1).DISCUSSION
The use of ultrasound guidance to perform diagnos-
tic and therapeutic injections is increasing rapidly. There
is a considerable amount of ultrasound-related informa-
tion available in the literature; however, there is very lit-
tle information related to ultrasound imaging of the face.Table 1. Soft tissue thickness
Point 1 Point 2 Point 3
Skin
All 1.0 § 0.2 1.1 § 0.1 1.3 § 0.2
Male 1.1 § 0.2 1.1 § 0.2 1.3 § 0.2
Female 0.9 § 0.2 1.0 § 0.1 1.2 § 0.2
p Value 0.032* 0.103 0.022*
Subcutaneous tissue
All 1.0 § 0.3 0.7 § 0.3 0.8 § 0.3
Male 1.1 § 0.3 0.8 § 0.3 0.9 § 0.3
Female 0.9 § 0.2 0.7 § 0.2 0.7 § 0.2
p Value 0.013* 0.047* 0.018*
Muscle
All 1.9 § 0.5 1.8 § 0.4 2.2 § 0.5
Male 1.9 § 0.5 1.8 § 0.4 2.2 § 0.5
Female 1.8 § 0.5 1.7 § 0.4 2.1 § 0.5
p Value 0.231 0.451 0.621
Loose connective tissue
All 0.6 § 0.2 0.8 § 0.2 0.8 § 0.2
Male 0.6 § 0.2 0.8 § 0.2 0.8 § 0.2
Female 0.6 § 0.1 0.7 § 0.1 0.7 § 0.1
p Value 0.118 0.168 0.046*
Total
All 4.5 § 0.8 4.3 § 0.7 5.0 § 0.7
Male 4.8 § 0.8 4.5 § 0.7 5.2 § 0.7
Female 4.1 § 0.7 4.1 § 0.6 4.6 § 0.6
p Value 0.006* 0.043* 0.006*
Results expressed as the mean § standard deviation in millimeters.
* p value < 0.05.The reason for this discrepancy is very simple: anatomi-
cal differences between skeletal and facial expression
muscles (Sauer et al. 2016; Volk et al. 2013, 2014).
Facial expression muscles differ from skeletal
muscles in several ways. First, in contrast to typical skel-
etal muscles, facial muscles are not surrounded by a fas-
cia. This means that if facial muscles are arranged in
multiple layers, it becomes very difficult to identify the
boundaries between muscles in ultrasound images. Sec-
ond, in contrast to typical skeletal muscle mass, the
facial expression muscles are thin and flat, which also
makes it very difficult to identify overlapping facial mus-
cle groups. Third, in contrast to typical skeletal muscle
insertions, facial muscles merge together, which makes
it impossible to separate the muscles in ultrasound
images. All of these characteristics make it difficult to
establish ultrasound guidelines for facial muscles. How-
ever, an awareness of various morphologic factors and
variations in facial muscles may be more helpful in
developing an ultrasound-guided injection technique.
Ultrasound is one of the most commonly used devices
in image-guided injection techniques. Injections were tradi-
tionally performed without visual guidance, requiring the
clinician to have a certain degree of experience, delicacy
and anatomic know-how. But even experienced clinicians
cannot guarantee success in the traditional hit-or-miss
approach, and so today clinicians largely avoid this by uti-
lizing guiding technologies such as ultrasound. Once the
clinician has identified anatomic landmarks on thees at the various points
Point 4 Point 5 Point 6 Point 7
1.1 § 0.2 1.1 § 0.2 1.0 § 0.2 1.1 § 0.2
1.1 § .0.2 1.1 § 0.2 1.1 § 0.1 1.1 § 0.1
1.0 § 0.2 1.0 § 0.2 0.9 § 0.1 1.0 § 0.2
0.064 0.267 0.008* 0.072
0.8 § 0.2 0.9 § 0.3 0.8 § 0.2 0.7 § 0.2
0.8 § 0.3 1.0 § 0.3 0.9 § 0.2 0.8 § 0.2
0.8 § 0.2 0.8 § 0.2 0.8 § 0.3 0.6 § 0.2
0.391 0.103 0.119 0.002*
1.6 § 0.5 2.2 § 0.5 1.8 § 0.4 1.6 § 0.4
1.5 § 0.4 2.2 § 0.4 1.8 § 0.4 1.7 § 0.3
1.8 § 0.5 2.2 § 0.5 1.8 § 0.5 1.4 § 0.3
0.103 0.687 0.674 0.016*
0.9 § 0.2 1.1 § 0.2 1.2 § 0.3 1.4 § 0.3
1.0 § 0.2 1.2 § 0.2 1.3 § 0.2 1.5 § 0.3
0.7 § 0.1 1.0 § 0.1 1.2 § 0.4 1.4 § 0.3
0.000* 0.047* 0.867 0.317
4.4 § 0.7 5.3 § 0.7 4.9 § 0.8 4.7 § 0.7
4.5 § 0.6 5.4 § 0.6 5.0 § 0.6 5.0 § 0.6
4.3 § 0.7 5.1 § 0.7 4.7 § 0.9 4.4 § 0.7
0.507 0.191 0.090 0.001*
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using a standard needle and syringe.
The most important aspect differentiating the present
study from other ultrasonographic studies is that the trans-
ducer was used without applying any pressure on the skin.
Most previous ultrasound images were obtained while
applying pressure with direct contact between the skin
and the transducer to observe deep structures such as
muscles, blood vessels and the intrauterine fetus. How-
ever, we attempted to observe the entire layered structure
without such deformation and to measure the soft tissue
thicknesses of all layers from the skin to the periosteum.
The application of a sufficient amount of gel allowed
ultrasound images to be obtained without any direct con-
tact or pressure between the transducer and the skin.
Clinicians need to be able to clearly distinguish the
layered structure of the facial muscles through ultrasound
imaging. The results of this study indicate that the five-layer
structure of the forehead (skin, subcutaneous layer, muscle
layer, loose connective tissue layer and periosteum) can be
distinguished using ultrasound with comparative ease at all
of the points analyzed. Though it is slightly difficult to
distinguish between the skin and the subcutaneous layer,
the muscle and the loose connective -tissue layer—which
are the main injection targets—can be clearly distinguished.
We found that the thicknesses of the skin and muscle
layers decreased from medial to lateral positions, whereas
the thickness of the loose connective tissue layer increased.
Along reference line HL1, point 3 and points 57, the skin
thickness gradually decreased to 1.26, 1.07, 1.07 and
1.01 mm. The muscle layers exhibited a similar tendency.
In contrast, the thickness of the loose connective tissue
layer gradually increased to 0.75, 1.11, 1.25 and 1.43 mm.
This can be explained by the existence of ROOF, located at
the lateral forehead, especially at points 6 and 7.
Both the skin and subcutaneous tissue thicknesses
indicate the distance from the skin to the surface of the
frontalis. The maximum value was 2.0 mm at point 3. In a
similar manner, the thicknesses of the skin, theTable 2. Soft tissue thicknesses of the v
Point 1 Point 2 Point 3
Skin + subcutaneous tissue
All 2.0 § 0.2 1.8 § 0.3 2.0 § 0.3y
Male 2.2 § 0.4 1.9 § 0.3 2.2 § 0.3
Female 1.8 § 0.3 1.7 § 0.3 1.8 § 0.2
p Value 0.001* 0.012* 0.000*
Skin + Subcutaneous tissue + muscle
All 3.9 § 0.7 3.6 § 0.6 4.2 § 0.7
Male 4.1 § 0.7 3.7 § 0.6 4.4 § 0.7
Female 3.6 § 0.7 3.4 § 0.6 3.9 § 0.6
p Value 0.015* 0.087 0.033*
Results expressed as the mean § standard deviation in millimeters.
* p value < 0.05.
y The minimum depth from the skin to exclude the muscle layer was 2.3 m
z The maximum depth from the skin to include the muscle layer was 2.8 msubcutaneous tissue and the muscle layer define the dis-
tance from the skin to the muscle border, which includes
the frontalis. The minimum value was 3.3 mm at point 7.
Allowing for the error range, the maximum value was
2.3 mm (2.0 mm+ 0.3 mm), and the minimum value was
2.8 mm (3.3mm  0.5 mm). There were significant differ-
ences in both the skin and subcutaneous tissues between
males and females. Among the seven points, the maximum
gap between the two layers was 0.4 mm at point 1, but this
small difference is not widely applicable to injectable
treatments in clinical applications (p< 0.05; Table 2).
These values mean that an injection at a depth of
about 2.5 mm (and within depths ranging from 2.32.8
mm) will target only the frontalis at all points on the
forehead, with the exception of point 1, where the fronta-
lis does not exist (Fig. 5).
This study was subject to some limitations. First, as only
40 Korean patients were analyzed, the results might only be
representative of the Korean population. Further research is
therefore needed to identify if similar tendencies are observed
in other populations. Second, this study focused on the lay-
ered structure and thickness of the forehead and not the nerve
and artery distributions. The results obtained therefore cannot
be used to provide an injection guide for targeting nerve
twigs or avoiding blood vessels in the forehead region.
Because the supratrochlear and supraorbital nerve branches
are so thin, it is impossible to detect them using ultrasound. It
is theoretically possible to avoid blood vessels when inserting
a needle under ultrasound guidance, but this method is rarely
used because of its inconvenience in clinical applications.
Third, this study focused on healthy patients aged 2030 y
to confirm the normal structures observed by ultrasound.
This limits the ability to apply the results to older people and
those with soft tissue diseases of the forehead.CONCLUSIONS
Clinicians can use an ultrasound device to identify
the layers of the scalp. If they do not perform injectionsarious layers from skin to muscle
Point 4 Point 5 Point 6 Point 7
1.9 § 0.3 2.0 § 0.3 1.8 § 0.3 1.8 § 0.3
1.9 § 0.3 2.0 § 0.3 2.0 § 0.3 1.9 § 0.2
1.8 § 0.3 1.8 § 0.3 1.7 § 0.3 1.6 § 0.3
0.097* 0.045* 0.012* 0.001*
3.5 § 0.6 4.1 § 0.6 3.6 § 0.7 3.3 § 0.5z
3.5 § 0.5 4.2 § 0.6 3.8 § 0.6 3.6 § 0.5
3.5 § 0.6 4.1 § 0.7 3.5 § 0.7 3.0 § 0.5
0.678 0.466 0.138 0.001*
m (2.0 mm + 0.3 mm).
m (3.3 mm  0.5 mm).
Fig. 5. Botulinum toxin type A should be injected in the forehead region at a depth ranging from 2.32.8 mm. For an
injection at a depth of exactly 2.5 mm, the needle can approach via only the intramuscle layer of the frontalis.
2648 Ultrasound in Medicine & Biology Volume 45, Number 10, 2019with ultrasound guidance, it is possible to target only
muscle layers using BoNT-A by injecting with the nee-
dle at a depth of around 2.5 mm. For the filler injections
that target the loose connective tissue layer, it is rela-
tively easy for clinicians to detect when the needle has
contacted the bone. If the injection is performed after
touching the bone, clinicians can specifically target only
the loose connective tissue layer.
Clinicians can utilize the present results to easily
perform various injectable treatments in the forehead
region.
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